Search by Drug Name or NDC
NDC 00143-9566-01 Azathioprine Sodium 100 mg/10mL Details
Azathioprine Sodium 100 mg/10mL
Azathioprine Sodium is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hikma Pharmaceuticals USA Inc.. The primary component is AZATHIOPRINE SODIUM.
Product Information
| NDC | 00143-9566 |
|---|---|
| Product ID | 0143-9566_c16b0808-bf65-41c1-857f-1667c0344401 |
| Associated GPIs | 99406010102110 |
| GCN Sequence Number | 011681 |
| GCN Sequence Number Description | azathioprine sodium VIAL 100 MG INJECTION |
| HIC3 | Z2E |
| HIC3 Description | IMMUNOSUPPRESSIVES |
| GCN | 46760 |
| HICL Sequence Number | 007825 |
| HICL Sequence Number Description | AZATHIOPRINE SODIUM |
| Brand/Generic | Generic |
| Proprietary Name | Azathioprine Sodium |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Azathioprine Sodium |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 100 |
| Active Ingredient Units | mg/10mL |
| Substance Name | AZATHIOPRINE SODIUM |
| Labeler Name | Hikma Pharmaceuticals USA Inc. |
| Pharmaceutical Class | Nucleic Acid Synthesis Inhibitors [MoA], Nucleosides [CS], Purine Antimetabolite [EPC], Purines [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA074419 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00143-9566-01 (00143956601)
| NDC Package Code | 0143-9566-01 |
|---|---|
| Billing NDC | 00143956601 |
| Package | 1 VIAL in 1 BOX, UNIT-DOSE (0143-9566-01) / 10 mL in 1 VIAL |
| Marketing Start Date | 1995-05-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |